Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...

The rapid growth of artificial intelligence/machine learning (AI/ML ... aligning well with its AI/ML-driven platform. Price Action: ABSI stock is up 23% at $3.96 at the last check on Wednesday.

"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...

According to a 2023 PwC report, the AI market in healthcare was valued at $11 billion and is expected to grow to $188 billion by 2030. On January 21st, Oracle Co-founder Larry Ellison said during a ...

Absci Corp. (NASDAQ:ABSI) shares, currently trading at $3.22, received a positive outlook from Needham as the firm began coverage with a Buy rating and set a price target of $9.00. The stock has shown ...

In this article, we are going to take a look at where Absci Corporation (NASDAQ:ABSI) stands against the other medical AI stocks. Investments in the global healthcare industry have ramped up ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street's Radar. In this article, we are going to take a look at where Absci Corporation (NASDAQ:ABSI) stands against the other ...

Needham has recently initiated Absci Corp (ABSI) stock to Buy rating, as announced on Today, according to Finviz. Earlier, on October 2, 2024, Guggenheim had initiated the stock to Buy, setting a ...

Guggenheim has recently initiated Absci Corp (ABSI) stock to Buy rating, as announced on October 2, 2024, according to Finviz. Earlier, on July 3, 2024, Morgan Stanley had initiated the stock to ...